HomeCompareISOL vs PFE

ISOL vs PFE: Dividend Comparison 2026

ISOL yields 1000000.00% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ISOL wins by $4.7683925249533696e+36M in total portfolio value
10 years
ISOL
ISOL
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full ISOL calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — ISOL vs PFE

📍 ISOL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodISOLPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ISOL + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ISOL pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ISOL
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, ISOL beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ISOL + PFE for your $10,000?

ISOL: 50%PFE: 50%
100% PFE50/50100% ISOL
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

ISOL
No analyst data
Altman Z
-13.1
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ISOL buys
0
PFE buys
0
No recent congressional trades found for ISOL or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricISOLPFE
Forward yield1000000.00%6.20%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$4.7683925249533696e+36M$51.1K
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$27,210.54
Total dividends collected$4.7683311610149396e+36M$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ISOL vs PFE ($10,000, DRIP)

YearISOL PortfolioISOL Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$100,010,700$100,000,000.00$9,161$701.38+$100.00MISOL
2$934,786,450,701$934,679,439,252.34$8,610$859.79+$934786.44MISOL
3$8,165,787,108,578,292$8,164,786,887,076,042.00$8,366$1,081.25+$8165787108.57MISOL
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$8,483$1,405.66+$66665884190957.64MISOL
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$9,084$1,907.24+$508662171058048128.00MISOL
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$10,418$2,732.78+$3.62723524842849e+21MISOL
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$13,007$4,193.56+$2.417368115915061e+25MISOL
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$18,010$7,005.87+$1.5056740286145463e+29MISOL
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$28,216$12,979.89+$8.764771002818475e+32MISOL
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$51,081$27,210.54+$4.7683925249533696e+36MISOL

ISOL vs PFE: Complete Analysis 2026

ISOLStock

1mage Software Inc operates in the technology industry. The company offers capturing services, including 1ACCESS, an java-based software application that utilizes the adobe PDF format, which could be printed, faxed, and emailed; application program interfaces consisting of executable subroutines; 1FAX, an software application that manages inbound/outbound fax transmissions and outbound emails; 1SCAN, a windows based software application; and 1ERM that provides simultaneous and multi-user access to indexed and archived computer-generated reports and customer-related documents. Its capturing services also include 1SCANSERV, which allow scanned documents from an MFP or a scanner to be transformed into image files; V1A, a document imaging software that allows viewing images; and Zoë, which gives access to other outside applications. The company also provides integrating services, such as application program interfaces; Zoë that gives access to other outside applications; ZoëFetch, an application bridge, which works with various applications; and Zoë XML Web services that allows users to seamlessly integrate with line of business application. In addition, it offers archiving services; and digital content management system that provides solutions for the scanning, indexing, storing, and retrieving of document images. Further, the company provides 1SEARCH that locate and retrieve documents/images, as well as Web services. Additionally, it offers exporting services, which include 1PUBLISH that enables users with specific security rights; and 1RENDITION, which automates the rendition billing process. The company is based in Centennial, Colorado.

Full ISOL Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this ISOL vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ISOL vs SCHDISOL vs JEPIISOL vs OISOL vs KOISOL vs MAINISOL vs JNJISOL vs MRKISOL vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.